Dr. Richard Moore is recognized for mentorship of medical students, residents, fellows, and junior faculty in HIV/AIDS Research. Winner of the David M. Levine Mentorship Awards in the General Internal Medicine Department, he is an expert in pharmacoepidemiology, clinical epidemiology, and health services research. Now serving as the Director of the Moore Clinic for HIV Care, which began in 1984, he has influenced the careers of young scholars not only in General Internal Medicine, but also in the Infectious Disease Division. His colleagues and mentees praise him for his accessibility, his patience, his scientific candor, his instinct for compelling research, his insight, and his abilities as a teacher and editor. Dr. Moore has authored 129 original manuscripts, 24 chapters, reviews and letters. For his medical degree he attended Vanderbilt University School of Medicine where he also completed his Internship and Residency in the Department of Medicine. A fellowship, completed at Johns Hopkins University, Department of Medicine, Division of Internal Medicine, was followed by a Masters of Health Sciences at the Johns Hopkins University, Bloomberg School of Public Health, Department of Epidemiology. Dr. Moore is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Sepsis, Hepatitis C, Hepatitis, and Gastrostomy.

Kathryn Anastos, MD is a physician executive, clinician and medical researcher who for more than 20 years has provided both clinical care and operational and clinical leadership in the South Bronx.  She has extensive experience in innovative development of large programs designed to increase access to high quality, culturally sensitive care by poor communities of color, while meeting both a clinical and financial bottom line. She has served as executive director of several large systems of ambulatory care in the Bronx, and has provided leadership during design, construction and opening of new primary care clinics.  Clinically Dr. Anastos trained and actively practices as a primary care internist with expertise in the comprehensive care of HIV infected individuals and HIV infection in women. Dr. Anastos is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Atherosclerosis, Sepsis, Menopause, and Endoscopy.

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School.  He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center.  Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is now the Harriet Ryan Albee Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital.  Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection.  He has chaired several multicenter studies of HIV therapy and previously chaired the AIDS Clinical Trials Group.  He has served on numerous NIH committees, including as a member of the NIH Office of AIDS Research Advisory Council.  He is a former member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy and a past Chair of the HIV Medicine Association Board of Directors.  He has been a member of several editorial boards, and serves as an Associate Editor of the Journal of Infectious Diseases.  His research interests focus on HIV therapeutics, antiretroviral drug resistance, HIV eradication and more recently, COVID-19. Dr. Kuritzkes is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce and Robert Beal Distinguished Chair, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, did his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital.He is Editor-in-Chief of Open Forum Infectious Diseases, is Section Editor of HIV/AIDS in UpToDate, on the Editorial Board of NEJM Journal Watch Infectious Diseases (where he writes the HIV and ID Observations blog), and on the editorial advisory board of Medscape HIV/AIDS. Dr. Sax is the Associate Program Director for the Mass General Brigham fellowship in Infectious Diseases, is on the core faculty of the International Antiviral Society – USA, and teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice and teaching, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group. Dr. Sax is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Gonorrhea, Chlamydia, and Sepsis.

Dr. Lichterfeld is an infectious disease physician at BWH and an Associate Professor at HMS. He is also an Associate Member of the Ragon Institute and of the Broad Institute of MIT and Harvard. He received his medical degree from the University of Heidelberg, Germany and completed his residency at Massachusetts General Hospital. In 2008-2011, he was an infectious disease fellow at the Brigham and Women’s Hospital and at Massachusetts General Hospital, with Dr. Eric Rosenberg as his mentor. He is a member of the American Association for Clinical Investigation, a fellow of the Infectious Disease Society of America, and has served as a chartered member of several study sections at the National Institutes of Health.Dr. Lichterfeld’s research interests focus on retroviral infections, specifically on HIV-1. His laboratory explores how HIV-1 can persist in the human body for a lifetime, despite very effective antiretroviral therapy that is available now; these studies involve a platform of recently-developed new technologies for single-cell profiling of virally-infected cells. Dr. Lichterfeld also leads clinical trials in which novel therapeutic approaches for HIV eradication and cure are evaluated; several of these studies are currently enrolling new patients. In collaboration with investigators from the Harvard School of Public Health, Dr. Lichterfeld’s lab also participates as a co-investigator in clinical trials with HIV-1-infected infants from Botswana. Dr. Lichterfeld is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Hepatitis.

Pablo Tebas is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Tebas is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex. Dr. Tebas is currently accepting new patients.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Roger Shapiro is an Internal Medicine provider in Boston, Massachusetts. Dr. Shapiro is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Woods Black Norbury Syndrome, Human Papillomavirus Infection, and Hepatitis B.

Dan Barouch is an Internal Medicine provider in Boston, Massachusetts. Dr. Barouch is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Zika Virus Disease, and COVID-19.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Frank Palella is an Infectious Disease provider in Chicago, Illinois. Dr. Palella has been practicing medicine for over 39 years and is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Valentina Stosor is an Infectious Disease provider in Chicago, Illinois. Dr. Stosor has been practicing medicine for over 34 years and is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, and Myelitis.

Douglas Krakower is an Internal Medicine provider in Boston, Massachusetts. Dr. Krakower is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Allison L. Agwu, MD, ScM, FAAP, FIDSA is Professor of pediatric and adult infectious diseases at the Johns Hopkins University School of Medicine. Her clinical interests include HIV/AIDS and infectious disease. Dr. Agwu earned her medical degree from the University of Maryland School of Medicine. She completed a residency in pediatrics and internal medicine at Case Western Reserve University (University Hospitals of Cleveland/ Rainbow Babies and Children’s Hospital), and a combined fellowship in pediatric and adult infectious diseases at the Johns Hopkins School of Medicine. Dr. Agwu's clinical and research interests focuses on children, adolescents, and young adults who are at-risk or living with HIV and their families. Clinically, she provides inpatient and outpatient pediatric infectious diseases' consultations and leads the Pediatric Adolescent HIV/AIDS Program, which provides multidisciplinary for those living with or affected by HIV. Further, she leads the young adult transition clinic, the Accessing Care Early (ACE) Clinic. Both programs are longstanding Ryan White Federal Grant-funded programs. Her overarching research goal is to decipher, address, and minimize disparities in treatment and outcomes for those living with HIV. Toward this goal, she oversees her own independent, longstanding, federally funded clinical research program and serves as principal investigator of the Johns Hopkins sites of the International Maternal, Pediatric, and Adolescent AIDS Clinical Trials (IMPAACT) Network and the Adolescent Trials' Network (ATN). Her research interests include optimizing outcomes for youth at-risk for and living with HIV, management and treatment strategies, and minimizing disparities in the use of antiretroviral therapy (ART) and outcomes. Other special interests include epidemiologic approaches to HIV, drug resistance, and clinical trials. She is a member of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Dr. Agwu is Chair of the HIV Medicine Association. Dr. Agwu is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Gonorrhea, Chlamydia, and COVID-19.

Wendy Armstrong is an Infectious Disease provider in Aurora, Colorado. Dr. Armstrong has been practicing medicine for over 32 years and is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.